Search
Search Results
##search.searchResults.foundPlural##
-
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1305PDF: 860HTML: 1031Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 175 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2195PDF: 943HTML: 5061Cover Letter: 169Figure 2: 160Figure 1: 173Figure 3: 195Figure 4: 166Figure Legend: 186Table 1: 188Table 2: 180Table 3: 179 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2174PDF: 1197HTML: 3709 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2602PDF: 1605HTML: 2354Table1: 190 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1111PDF: 487HTML: 230 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1190PDF: 1061HTML: 201 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3683PDF: 1437HTML: 182 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1954PDF: 711HTML: 681Table1: patient's characteristics: 155Table 2: profile of each patient: 178 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2770PDF: 1807HTML: 3666Pellagatti Fig 1: 214Pellagatti Fig. 2: 209 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2544PDF: 1130HTML: 140 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2213PDF: 1044HTML: 1981Characteristic of study group: 196 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1838PDF: 832HTML: 1579 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
719PDF: 464HTML: 6265 -
Osteolytic bone lesions – A rare presentation of AML M6.
1965PDF: 1095HTML: 7935Untitled: 203 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7428PDF: 2419HTML: 1730Table 1.: 208Table 2.: 217Table 3.: 201Table 4.: 200 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3144PDF: 1137HTML: 1484Untitled: 176Untitled: 165Untitled: 167 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1379PDF: 918HTML: 1651Figure 1: 178 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1540PDF: 760HTML: 2137Untitled: 222Untitled: 193Untitled: 194Untitled: 200Untitled: 198 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1711PDF: 765HTML: 504 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277648PDF: 1791HTML: 3864 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1773PDF: 699HTML: 336 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9048PDF: 6054HTML: 87951Fig.1b: 184Fig.1c: 188Fig.2a: 176Fig.2b: 175Fig.4: 188Fig.2c: 183Fig.3: 181Tab.1: 225Tab.2: 206Tab.3: 188Tab.4: 220Fig1a: 181 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1904PDF: 1214HTML: 237 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1693PDF: 1096HTML: 10695Untitled: 188 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4654PDF: 1313HTML: 1911Untitled: 180Untitled: 175 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2167PDF: 1583HTML: 264 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2189PDF: 1483HTML: 264







